Loading…
Genenta Science S.p.A. is projected to rise to $0.9102 by 2027, a +11% move from its current price of $0.8205. GNTA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.7774 | $0.82 | $0.8649 | -0.06% |
| May 30 | $0.7599 | $0.8194 | $0.8836 | -0.13% |
| May 31 | $0.7466 | $0.8189 | $0.8981 | -0.19% |
| Jun 1 | $0.7356 | $0.8184 | $0.9105 | -0.26% |
| Jun 2 | $0.7259 | $0.8178 | $0.9214 | -0.32% |
| Jun 3 | $0.7172 | $0.8173 | $0.9314 | -0.39% |
| Jun 4 | $0.7093 | $0.8168 | $0.9405 | -0.45% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.7093 | $0.8168 | $0.9405 | -0.45% |
| Week 2 | $0.666 | $0.8131 | $0.9926 | -0.91% |
| Week 3 | $0.6339 | $0.8094 | $1.03 | -1.35% |
| Week 4 | $0.6076 | $0.8057 | $1.07 | -1.80% |
| Week 5 | $0.585 | $0.8021 | $1.10 | -2.25% |
| Week 6 | $0.5651 | $0.7984 | $1.13 | -2.69% |
| Week 7 | $0.5472 | $0.7948 | $1.15 | -3.13% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Genenta Science S.p.A. is a clinical-stage biotechnology company that develops hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company offers Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter.
It is developing Temferon for use in the treatment of other solid tumor indications. In addition, the company develops biologic platform to deliver immunomodulatory molecules directly to the tumor by infiltrating monocytes/macrophages. Genenta Science S.p.A.
was incorporated in 2014 and is headquartered in Milan, Italy.
GNTA is currently priced at $0.8205 per share and trades with a market capitalization of $19.36M. The company is ranked 4905 by market cap. The overall price outlook reflected in the forecast shows a path from near-term stability toward longer-term upside, with the average price edging around the current level in 2026 and rising in several later years.
A major floor 39.1% below — a decisive break under it would weaken the trend.
The nearest floor, 29.3% below — buyers have tended to step in here.
Price is pressing into resistance (0.1% away) — a breakout level to watch.
A major ceiling 87.7% above — clearing it would confirm fresh momentum.
Key GNTA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of GNTA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.6412 | Buy | $0.6737 | Buy |
| MA 10 | $0.6306 | Buy | $0.6509 | Buy |
| MA 20 | $0.6506 | Buy | $0.6543 | Buy |
| MA 50 | $0.6799 | Buy | $0.7283 | Buy |
| MA 100 | $0.881 | Sell | $1.00 | Sell |
| MA 200 | $1.79 | Sell | $1.65 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 67.60 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 244.52 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 31.15 | Buy |
| Bollinger %B (20,2) | 1.24 | Sell |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | -0.52 | Sell |
| Awesome (5,34) | -0.03 | Sell |
| Ultimate (7,14,28) | 73.68 | Sell |
| Momentum (10) | 0.21 | Buy |
| Aroon Osc (25) | 8.00 | Buy |
| Hull MA (9) | 0.65 | Buy |
| ADX (14) | 19.45 | Neutral |
| ATR (14) | 0.03 | Info |
The 30-day technical picture is bullish overall, with RSI14 at 70 signaling strong momentum. The stock trades with a 50-day simple moving average of $0.6799 and a 200-day simple moving average of $1.79. Support is listed at $0.58 and resistance at $0.821.
The 30-day trading range spans from $0.5773 up to $1.17, indicating a broad consolidation near the current level.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.58 | $0.8205 | $1.09 | 0% | Neutral | |
| $0.6552 | $0.9102 | $1.37 | +11% | Neutral | |
| $0.5396 | $0.7955 | $1.27 | -3% | Neutral | |
| $0.4727 | $0.7334 | $1.23 | -11% | Neutral | |
| $0.4619 | $0.751 | $1.31 | -8% | Neutral | |
| $0.3991 | $0.6778 | $1.22 | -17% | Bearish | |
| $0.5124 | $0.9076 | $1.69 | +11% | Neutral | |
| $0.5872 | $1.08 | $2.07 | +32% | Bullish | |
| $0.5399 | $1.04 | $2.03 | +26% | Bullish | |
| $0.6041 | $1.20 | $2.41 | +47% | Bullish | |
| $0.6658 | $1.48 | $3.25 | +80% | Bullish | |
| $0.9831 | $2.18 | $5.02 | +166% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.58 | $0.8205 | $0.9799 | +0.00% |
| June 2026 | $0.6812 | $0.817 | $1.02 | -0.43% |
| July 2026 | $0.6341 | $0.7733 | $0.9855 | -5.34% |
| August 2026 | $0.635 | $0.7848 | $1.02 | +1.49% |
| September 2026 | $0.636 | $0.7947 | $1.05 | +1.27% |
| October 2026 | $0.5938 | $0.7497 | $1.00 | -5.67% |
| November 2026 | $0.5809 | $0.7401 | $1.00 | -1.28% |
| December 2026 | $0.6198 | $0.7964 | $1.09 | +7.62% |
Click any year to see its month-by-month GNTA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The GNTA price prediction for 2026 points to an average of $0.8205 (low $0.58, high $1.09) — a potential gain of 0% on today's $0.8205. A consolidation phase looks the most probable path here.
In 2027, GNTA is projected to trade between $0.6552 and $1.37, averaging $0.9102 — a potential gain of +11% from today's $0.8205. That is up +11% on the projected 2026 average. Price action looks broadly range-bound.
Genenta Science S.p.A.'s 2028 outlook centres on $0.7955, within a $0.5396 to $1.27 range. That is -13% versus the projected 2027 average. That marks a -3% change versus current levels. A consolidation phase looks the most probable path here.
By 2029, GNTA could reach as high as $1.23, with a base case around $0.7334 and support toward $0.4727 — roughly -11% from $0.8205. Price action looks broadly range-bound.
Expect GNTA to range from $0.4619 to $1.31 through 2030. The $0.751 average target implies a -8% move from current prices. That is up +2% on the projected 2029 average. A consolidation phase looks the most probable path here.
The GNTA price prediction for 2031 points to an average of $0.6778 (low $0.3991, high $1.22) — a potential decline of -17% on today's $0.8205. A cyclical pullback looks likely — prices rarely move in a straight line.
In 2032, GNTA is projected to trade between $0.5124 and $1.69, averaging $0.9076 — a potential gain of +11% from today's $0.8205. That is up +34% on the projected 2031 average. A consolidation phase looks the most probable path here.
Genenta Science S.p.A.'s 2033 outlook centres on $1.08, within a $0.5872 to $2.07 range. That is up +19% on the projected 2032 average. That marks a +32% change versus current levels. Momentum favours further upside here.
By 2034, GNTA could reach as high as $2.03, with a base case around $1.04 and support toward $0.5399 — roughly +26% from $0.8205. Buyers look set to stay in control over this stretch.
Expect GNTA to range from $0.6041 to $2.41 through 2035. The $1.20 average target implies a +47% move from current prices. That is up +16% on the projected 2034 average. Momentum favours further upside here.
The GNTA price prediction for 2040 points to an average of $1.48 (low $0.6658, high $3.25) — a potential gain of +80% on today's $0.8205. Buyers look set to stay in control over this stretch.
In 2050, GNTA is projected to trade between $0.9831 and $5.02, averaging $2.18 — a potential gain of +166% from today's $0.8205. That is up +48% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in GNTA today (≈ 1,218.769043 GNTA) could be worth
$2,662.74
+$1,662.74 (+166%) by 2050 · US Dollar
Based on the average projected GNTA price of $2.18 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in GNTAwould be worth at today's price.
$1,000 invested in GNTA on May 27, 2025 (≈ 228.832958 GNTA) would be worth
$187.76
-$812.24 (-81.2%) today · 0.19× · US Dollar
Based on a GNTA entry price of $4.37 vs. today's $0.8205.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.618 | $1,327.67 | +32.8% |
| 1 month ago | $0.738 | $1,111.79 | +11.2% |
| 3 months ago | $0.96 | $854.69 | -14.5% |
| 6 months ago | $2.01 | $408.21 | -59.2% |
| 1 year ago | $4.37 | $187.76 | -81.2% |
| All time (4.4y) ago | $11 | $74.59 | -92.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our GNTA forecast.
Our base-case forecast reaches $1.60 around 2050.
Implied market cap at $1.60: $37.75M
The multi-year forecast shows a mixed to bullish trajectory. In 2026 the average price is $0.8205 with a neutral sentiment and 0% ROI, rising to an average of $0.9102 in 2027 with a 10.9% ROI. The years 2028–2031 show modest declines and negative ROI, culminating in 2031 with an average of $0.6778 and a -17.4% ROI.
From 2032 onward, the forecast turns more constructive, with 2032 at $0.9076 (10.6% ROI), 2033 at $1.08 (32% ROI), 2034 at $1.04 (26.2% ROI), and 2035 at $1.20 (46.8% ROI). The long-horizon view points to stronger upside, with 2040 averaging $1.48 (80.3% ROI) and 2050 averaging $2.18 (166.3% ROI), both labeled bullish.
Tap a question to reveal the answer.
The forecast shows min $0.4619, avg $0.751, max $1.31 with ROI -8.5% and sentiment NEUTRAL.
Forecast figures demonstrate a mix of near-term softness and longer-term upside. For example, 2027 shows avg $0.9102 with ROI 10.9% and 2031 shows avg $0.6778 with ROI -17.4% (sentiment NEUTRAL to BEARISH inearly years), while 2040 and 2050 show bullish upside at 80.3% and 166.3% ROI respectively.
Yes. The 2033 forecast lists a max of $2.07, with an average of $1.08 and a min of $0.5872; the ROI is 32% in 2033.
The 2040 forecast shows an average price of $1.48, with a min of $0.6658 and a max of $3.25; ROI is 80.3% and sentiment is BULLISH.
Genenta Science S.p.A. Community Discussion
0Share your Genenta Science S.p.A. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.